[
  {
    "phenotype_id": "PH2132",
    "phenotype_version_id": 4857,
    "name": "Poly adenosine disphosphate-ribose polymerase (PARP) inhibitors systemic medication codes",
    "definition": "This codelist was taken from [OpenCodelists](https://www.opencodelists.org/), created by [OpenSAFELY](https://www.opensafely.org/). We recommend viewing this Phenotype on the OpenCodelist website to view the most recent version.\n\n\nTaken from the `PARPDRUG_COD` NHS drug refset. Contains public sector information licensed under the UK Open Government Licence v3\\.0 (https://www.nationalarchives.gov.uk/doc/open\\-government\\-licence/version/3/).\n\n\n© University of Oxford for the Bennett Institute for Applied Data Science 2025\\. This work may be copied freely for non\\-commercial research and study.\n\n",
    "implementation": null,
    "publications": null,
    "validation": null,
    "citation_requirements": null,
    "created": "2026-01-26T21:50:07.908280Z",
    "author": "NHS Drug Refsets",
    "collections": [
      {
        "name": "OpenCodelist",
        "value": 31
      },
      {
        "name": "Phenotype Library",
        "value": 18
      }
    ],
    "tags": null,
    "organisation": {
      "id": 1,
      "slug": "opensafely",
      "name": "OpenSAFELY"
    },
    "world_access": 1,
    "updated": "2026-01-26T21:50:09.090209Z",
    "references": [],
    "signed_off": [],
    "methodology": "",
    "coding_system": [
      {
        "name": "dm+d codes",
        "value": 23
      }
    ],
    "open_codelist_id": "nhs-drug-refsets/parpdrug_cod",
    "source_reference": "https://www.opencodelists.org/codelist/nhs-drug-refsets/parpdrug_cod/20250912",
    "concept_information": [
      {
        "concept_id": 5034,
        "concept_version_id": 12519,
        "concept_name": "nhs-drug-refsets/parpdrug_cod/20250912",
        "coding_system": {
          "id": 23,
          "name": "dm+d codes",
          "description": "dm+d codes"
        },
        "phenotype_id": "PH2132",
        "phenotype_version_id": 4857,
        "phenotype_name": "Poly adenosine disphosphate-ribose polymerase (PARP) inhibitors systemic medication codes",
        "code_attribute_header": [],
        "codes": [
          {
            "code": "29747411000001106",
            "description": "Lynparza 50mg capsules (AstraZeneca UK Ltd) (AMP)",
            "attributes": null
          },
          {
            "code": "29768811000001101",
            "description": "Olaparib 50mg capsules (VMP)",
            "attributes": null
          },
          {
            "code": "35017411000001108",
            "description": "Zejula 100mg capsules (GlaxoSmithKline UK Ltd) (AMP)",
            "attributes": null
          },
          {
            "code": "35018311000001100",
            "description": "Niraparib 100mg capsules (VMP)",
            "attributes": null
          },
          {
            "code": "35498711000001106",
            "description": "Lynparza 100mg tablets (AstraZeneca UK Ltd) (AMP)",
            "attributes": null
          },
          {
            "code": "35499011000001104",
            "description": "Lynparza 150mg tablets (AstraZeneca UK Ltd) (AMP)",
            "attributes": null
          },
          {
            "code": "35514811000001103",
            "description": "Olaparib 100mg tablets (VMP)",
            "attributes": null
          },
          {
            "code": "35514911000001108",
            "description": "Olaparib 150mg tablets (VMP)",
            "attributes": null
          },
          {
            "code": "35819211000001104",
            "description": "Rucaparib 200mg tablets (VMP)",
            "attributes": null
          },
          {
            "code": "35819411000001100",
            "description": "Rubraca 200mg tablets (pharmaand GmbH) (AMP)",
            "attributes": null
          },
          {
            "code": "35819611000001102",
            "description": "Rucaparib 250mg tablets (VMP)",
            "attributes": null
          },
          {
            "code": "35819811000001103",
            "description": "Rubraca 250mg tablets (pharmaand GmbH) (AMP)",
            "attributes": null
          },
          {
            "code": "35820011000001105",
            "description": "Rucaparib 300mg tablets (VMP)",
            "attributes": null
          },
          {
            "code": "35820211000001100",
            "description": "Rubraca 300mg tablets (pharmaand GmbH) (AMP)",
            "attributes": null
          },
          {
            "code": "37649611000001100",
            "description": "Talzenna 0.25mg capsules (Pfizer Ltd) (AMP)",
            "attributes": null
          },
          {
            "code": "37650611000001109",
            "description": "Talzenna 1mg capsules (Pfizer Ltd) (AMP)",
            "attributes": null
          },
          {
            "code": "37723111000001100",
            "description": "Talazoparib 1mg capsules (VMP)",
            "attributes": null
          },
          {
            "code": "37723211000001106",
            "description": "Talazoparib 250microgram capsules (VMP)",
            "attributes": null
          },
          {
            "code": "38374011000001106",
            "description": "Zejula 100mg capsules (Originalis B.V.) (AMP)",
            "attributes": null
          },
          {
            "code": "39240511000001100",
            "description": "Lynparza 100mg tablets (Originalis B.V.) (AMP)",
            "attributes": null
          },
          {
            "code": "39240711000001105",
            "description": "Lynparza 150mg tablets (Originalis B.V.) (AMP)",
            "attributes": null
          },
          {
            "code": "41448211000001105",
            "description": "Zejula 100mg tablets (GlaxoSmithKline UK Ltd) (AMP)",
            "attributes": null
          },
          {
            "code": "41546111000001107",
            "description": "Niraparib 100mg tablets (VMP)",
            "attributes": null
          },
          {
            "code": "42997511000001103",
            "description": "Talzenna 0.1mg capsules (Pfizer Ltd) (AMP)",
            "attributes": null
          },
          {
            "code": "43008411000001103",
            "description": "Talazoparib 100microgram capsules (VMP)",
            "attributes": null
          }
        ]
      }
    ],
    "coding_system_release": "",
    "open_codelist_version_id": "1ec37f73",
    "open_codelist_version_tag": "20250912",
    "status": 1,
    "doi": "https://doi.org/10.48533/6s8b-jr26",
    "is_deleted": false,
    "publish_status": 2,
    "owner": "ieuan.scanlon",
    "template": {
      "id": 3,
      "name": "OpenCodelists Phenotype",
      "description": "OpenSafely's OpenCodelist Phenotype, visit https://www.opencodelists.org/ to learn more",
      "version_id": 1
    },
    "versions": [
      {
        "version_id": 4857,
        "version_name": "Poly adenosine disphosphate-ribose polymerase (PARP) inhibitors systemic medication codes",
        "version_date": "2026-01-26T21:50:09.106450Z",
        "is_published": true,
        "is_latest": true
      },
      {
        "version_id": 4856,
        "version_name": "Poly adenosine disphosphate-ribose polymerase (PARP) inhibitors systemic medication codes",
        "version_date": "2026-01-26T21:50:07.920016Z",
        "is_published": true,
        "is_latest": false
      }
    ]
  }
]